Drugs that contain Budesonide

1. Drug name - ORTIKOS

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9707182 SUN PHARM INDS INC Oral pharmaceutical dosage forms of budesonide Sep, 2036

(13 years from now)

US10172802 SUN PHARM INDS INC Oral pharmaceutical dosage forms of budesonide Sep, 2036

(13 years from now)

Treatment: Treatment of mild to moderate active crohn's disease involving the ileum and/or the ascending colon

Dosage: CAPSULE, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
6MG CAPSULE, EXTENDED RELEASE;ORAL Prescription
9MG CAPSULE, EXTENDED RELEASE;ORAL Prescription

2. Drug name - TARPEYO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8491932 CALLIDITAS Compositions for the oral delivery of corticosteroids May, 2029

(6 years from now)

Treatment: Treatment of primary immunoglobulin a nephropathy (igan) in adults at risk of rapid disease progression

Dosage: CAPSULE, DELAYED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
4MG CAPSULE, DELAYED RELEASE;ORAL Prescription

3. Drug name - UCERIS

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8895064 SALIX Controlled release and taste masking oral pharmaceutical composition Sep, 2031

(8 years from now)

US10660858 SALIX Controlled release and taste masking oral pharmaceutical composition Sep, 2031

(8 years from now)

US9132093 SALIX Controlled release and taste making oral pharmaceutical composition Sep, 2031

(8 years from now)

US10307375 SALIX Controlled release and taste masking oral pharmaceutical composition Sep, 2031

(8 years from now)

US9192581 SALIX Controlled release and taste masking oral pharmaceutical composition Sep, 2031

(8 years from now)

Treatment: Induction of remission in patients with active, mild to moderate ulcerative colitis

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
9MG TABLET, EXTENDED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.